Clinical trial
Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis…
NCT00357279 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00357279 |
|---|---|
| Title | Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease |
| Official title | A Multi-Center, Double-Blind, Placebo-Controlled Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Inhalation Solution, Placebo - 0.9% w/v sodium chloride solution |
| Enrollment | 352 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 27, 2006 |
| Last update posted | Nov 4, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: